Bifidobacterium Market Report

Industry revenue for Bifidobacterium is estimated to rise to $3.0 billion by 2035 from $1.4 billion of 2024. The revenue growth of market players is expected to average at 7.4% annually for the period

Brazil, South Africa, and Indonesia: The New Frontiers for Bifidobacterium Market Players

Brazil, South Africa, and Indonesia are emerging as the fastest-growing demand hubs in the $1.4 billion Bifidobacterium market, expected to grow at a CAGR of 4.8% to 7.1% between 2025 and 2030. Key application areas include probiotic supplements and infant formula, where market competition is fierce.

Bifidobacterium plays a crucial role in fortified infant nutrition, with Bifidobacterium lactis being the most preferred strain for its immune-boosting and nutrient absorption capabilities. Top global infant formula brands like Nestlé and Enfamil are leveraging these benefits to maintain a competitive edge in the nutrition sector.


Market Leaders and Strategic Developments

Prominent industry players such as:

  • DuPont Danisco

  • Chr. Hansen Holding A/S

  • Lallemand Inc

  • Probi AB

  • UAS Labs LLC

  • BioGaia AB

  • Morinaga Milk Industry Co. Ltd

  • Yakult Honsha Co Ltd

  • DSM NV

  • Nestlé SA

are actively investing in innovation and forging strategic alliances to enhance product offerings and expand market reach.

📘 Access Detailed Report


Industry Shift Towards Probiotic-Enriched Foods

There has been a marked industry shift toward the inclusion of Bifidobacterium in functional foods. This trend is largely driven by:

  • Increasing awareness of gut health

  • Consumer demand for natural and probiotic-rich diets

  • Growing popularity of dairy products fortified with Bifidobacterium

This transformation is prompting F&B manufacturers to reformulate their offerings with probiotic functionality, boosting both innovation and industry growth.


Global & Regional Growth Outlook

According to DataString Consulting, the Bifidobacterium market is projected to double from $1.4 billion in 2024 to $3.0 billion by 2035, growing at a CAGR of 7.4%.

North America Focus

  • Strong uptake of Bifidobacterium supplements

  • High public awareness around digestive and immune health

  • Robust pharma and food sectors driving product integration

  • Competitive landscape shaped by regulatory clarity and proactive consumer behavior


Market Research Scope & Segmentation

🔹 Product Form

  • Powder

  • Liquid

  • Capsules

🔹 End-Users

  • Food & Beverages

  • Dietary Supplements

  • Pharmaceuticals

  • Animal Feed

  • Others

🔹 Delivery Mode

  • Oral

  • Topical

🔹 Life Stage Specific

  • Infant

  • Adult

  • Elderly

🔹 Therapeutic Areas

  • Digestive Health

  • Immune Health

  • Cardiovascular Health

📥 Download Free Sample


About DataString Consulting

DataString Consulting is a premier provider of customized market research and business intelligence, serving both B2B and B2C organizations worldwide. Backed by over 30 years of leadership experience, we offer:

  • Tailored insights for strategic decision-making

  • Scalable reports starting from USD 1,399

  • A collaborative model that bridges firms, consultancies, and corporate teams

We’re shaping the future of affordable, high-impact research without the limitations of traditional models.


📩 Contact Us Mr. Mark Lawson Email: mlawson@datastringconsulting.com | sales@datastringconsulting.com

Last updated